Real-world-data on efficacy and safety of topical budesonide therapy (orodispersible tablet) in induction and maintenance therapy in adult patients with active eosinophilic esophagitis
BUD-ODT demonstrated high effectiveness in inducing and maintaining remission in a real-world setting. The spectrum of side effects did not reveal any new aspects compared to known clinical data.
Authors
- Ulrike von Arnim (ORCID: https://orcid.org/0000-0003-3214-0166)
- Max Weisfeld
- Silke Meszaros
- Stephan Miehlke (ORCID: https://orcid.org/0000-0002-9297-3349)
- Verena Keitel (ORCID: https://orcid.org/0000-0003-1383-7662)
Institutions
- University Medical Center Hamburg-Eppendorf (DE)
- University Hospital Magdeburg (DE)
- Dr Falk Pharma (Germany) (DE)
Publication Details
- Journal
- Therapeutic Advances in Gastroenterology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/17562848251382791
- Primary Topic
- Eosinophilic Esophagitis
- Type
- article
- Field-Weighted Citation Impact
- 0.00